Basic and Diluted Net (Loss) Income per Share (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the Company’s basic and diluted net (loss) income per share attributable to common stockholders for the three months ended March 31 (in thousands, except share and per share amounts):


	Three Months Ended March 31,
		2026	2025
			Class A		Class V		Class A		Class V
Numerator:
Net (loss) income attributable to common stockholders, basic			$	(88,736)	$	(3,379)	$	47,617	$	1,868

Reallocation of undistributed earnings			—		—		187		(187)
Net (loss) income attributable to common stockholders, diluted			(88,736)		(3,379)		47,804		1,681

Denominator:
Weighted average shares outstanding, basic			219,979,680		8,377,623		213,611,704		8,377,623
Effect of dilutive potential common shares			—		—		24,620,905		—
Weighted average shares outstanding, diluted			219,979,680		8,377,623		238,232,609		8,377,623

Basic net (loss) income per share			$	(0.40)	$	(0.40)	$	0.22	$	0.22
Diluted net (loss) income per share			$	(0.40)	$	(0.40)	$	0.20	$	0.20

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table discloses weighted-average Class A securities that were not included in the computation of diluted net (loss) income per share as their inclusion would have been anti-dilutive:


	Three Months Ended March 31,
		2026	2025
RSUs		14,701,819	913,504
Convertible notes		14,149,300	—
Stock options		9,603,189	—
Common stock issuable under the ESPP		703,226	—
Warrants to purchase Class A common stock		271,962	—

Hims & Hers Health, Inc. 10-Q